Calgary, AB – TheNewswire – December 27, 2024 – Universal Ibogaine Inc. (TSXV:IBO) (“UI” or the “Company”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, provides the following bi-weekly default status report update:
Management Cease Trade Order (“MCTO”)
Further to the Company’s prior news releases ...